An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients

Hepatology International

Volumn 10, Issue 4, 2016, Pages 640-646

  Liu, Yong kang ^a   Hu, Bao shan ^b   Li, Zhong liang ^b   He, Xu ^b   Li, Yong ^b   Lu, Li gong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Circulating tumor cells; Epithelial mesenchymal transition; Hepatocellular carcinoma; Metastasis

Indexed keywords

MESSENGER RNA; RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL COUNT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENOMIC IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; VERY ELDERLY; BLOOD; GENETICS; IN SITU HYBRIDIZATION; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; RETROSPECTIVE STUDIES; RNA, NEOPLASM;

EID: 84978132210     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-016-9732-7     Document Type: Article

References (30)

1. Parkin DM, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94(2):153–156
2. Ferenci P, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010;44(4):239–245.
3. Cabrera R, Nelson DR. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2010;31(4):461–476
4. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4(6):448–456
5. Imamura H, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38(2):200–207
6. Bednarz-Knoll N, Alix-Panabieres C, Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 2011;13(6):228
7. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2(6):442–54.
8. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119(6):1420–1428
9. Kalluri R. EMT: When epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009;119(6):1417–1419
10. Osta WA, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004;64(16):5818–5824
11. Giuliano M, et al. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res 2011;13(3):R67
12. Larsson A, et al. Increased cell proliferation and neurogenesis in the hippocampal dentate gyrus of old GFAP(−/−)Vim(−/−) mice. Neurochem Res 2004;29(11):2069–2073
13. McInroy L, Maatta A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007;360(1):109–114
14. Yu W, Kamara H, Svoboda KK. The role of twist during palate development. Dev Dyn 2008;237(10):2716–2725
15. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 2007;253(2):180–204
16. Weissenstein U, et al. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies. BMC Cancer 2012;12:206
17. Deng G, et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 2008;10(4):R69
18. Yu M, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339(6119):580–584
19. Gorges TM, et al. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 2012;12:178
20. Wu S, et al. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions. Clin Chem Lab Med (CCLM) 2014;52(2):243–251
21. Zhang Y, et al. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Semin Oncol 2012;39(4):449–460
22. Talasaz AH, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci USA 2009;106(10):3970–3975
23. Andreopoulou E, et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex Cell Search system. Int J Cancer 2012;130(7):1590–1597
24. Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the cell search system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010;2010:617421
25. Sun YF, et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 2013;57(4):1458–1468
26. Allard WJ, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10(20):6897–6904
27. Cristofanilli M, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23(7):1420–1430
28. Matthew EM, et al. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells. Oncotarget 2016;7(4):3662–3676
29. Mani SA, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133(4):704–715
30. Vesuna F, et al. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 Expression1. Neoplasia 2009;11(12):1318–1328